Sartorius AG

Company Profile

• Business description

  Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

• Contact

  Otto-Brenner-Strasse 20
  GottingenNI37079
  DEU

  T: +49 5513080

  E: [email protected]

  https://www.sartorius.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Medical Instruments & Supplies

  Fiscal Year End

  31 December 2025

  Employees

  13,528